UBS Tests ZKSync's Layer-2 Tech, Showing Deeper TradFi Interest in Crypto
The Swiss banking giant, which has been experimenting with blockchain, tapped the layer-2 firm to test whether it could scale ...
ResMed upgraded to Buy at UBS as risks skew positive, consensus too cautious
UBS upgraded ResMed (RMD) to Buy from Neutral with a price target of $290, up from $255. The firm thinks consensus is too cautious in the ...
UBS Keeps Their Buy Rating on Visa (V)
UBS analyst Timothy Chiodo maintained a Buy rating on Visa (V – Research Report) today and set a price target of $400.00. The company’s shares ...
UBS ETFs update index names and fund titles to align with benchmarks
ETF PLC, a subsidiary of the global financial services company UBS Group AG (NYSE:UBS), has announced a series of index renaming and corresponding ETF name changes, effective February 3, 2025, for ...
UBS maintains Neutral Apple stock with $236 target
UBS reiterated a Neutral rating on Apple stock (NASDAQ:AAPL), maintaining a price target of $236.00. The commentary from UBS followed Apple's report on its December quarter iPhone revenue, which ...